PTEN and neoplasm: miR‐103a can be transferred to monocytes where it can inhibit the expression of PTEN by direct targeting, leading to the activation of PI3K/Akt and STAT3 signalling pathways, finally resulting in a switch towards the tumour‐promoting macrophage polarization (Hsu et al., 2018).